The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Liver disease induced by radioembolization of liver tumors: Description and possible risk factors
Open accessAbstract
BACKGROUND: To the authors' knowledge, liver damage after liver radioembolization with yttrium90‐labeled microspheres has never been studied specifically. METHODS: Using a complete set of data recorded prospectively among all patients without previous chronic liver disease treated by radioembolization at the authors' institution from September 2003 to July 2006, patterns of liver damage were identified and possible risk factors were analyzed. RESULTS: In all, 20% of patients developed a distinct clinical picture that appeared 4 to 8 weeks after treatment and was characterized by jaundice and ascites. Veno‐occlusive disease was the histologic hallmark observed in the most severe cases. This form of sinusoidal obstruction syndrome was not observed among patients who never received chemotherapy or in those in whom a single hepatic lobe was treated. Relevant to treatment planning, a possible risk factor was a higher treatment dose in relation to the targeted liver volume. A transjugular intrahepatic stent shunt improved liver function in 2 patients with impending liver failure, although 1 of them eventually died from it. CONCLUSIONS: Radioembolization of liver tumors, particularly after antineoplastic chemotherapy, may result in an uncommon but potentially life‐threatening form of hepatic sinusoidal obstruction syndrome that presents clinically with jaundice and ascites. Cancer 2008. © 2008 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A REVIEW OF GOODNESS OF FIT STATISTICS FOR USE IN THE DEVELOPMENT OF LOGISTIC REGRESSION MODELS1
LEMESHOW, S., & HOSMER, D. W. (1982) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113284 · Cited by 1,947
Rubbia-Brandt, L., Audard, V., Sartoretti, P., Roth, A. D., Brezault, C., Le Charpentier, M., Dousset, B., Morel, P., Soubrane, O., Chaussade, S., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh095 · Cited by 1,038
Hepatic toxicity resulting from cancer treatment
Lawrence, T. S., Robertson, J. M., Anscher, M. S., Jirtle, R. L., Ensminger, W. D., & Fajardo, L. F. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)00418-k · Cited by 721
Gray, B., Van Hazel, G., Hope, M., Burton, M., Moroz, P., Anderson, J., & Gebski, V. (2001) · Annals of Oncology · doi:10.1023/a:1013569329846 · Cited by 526
van Hazel, G., Blackwell, A., Anderson, J., Price, D., Moroz, P., Bower, G., CARDACI, G. T., & Gray, B. N. (2004) · Journal of Surgical Oncology · doi:10.1002/jso.20141 · Cited by 442
Salem, R., Lewandowski, R. J., Atassi, B., Gordon, S. C., Gates, V. L., Barakat, O., Sergie, Z., Wong, C.-Y. O., & Thurston, K. G. (2005) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000184594.01661.81 · Cited by 404
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma
Geschwind, J. F. H., Salem, R., Carr, B. I., Soulen, M. C., Thurston, K. G., Goin, K. A., van Buskirk, M., Roberts, C. A., & Goin, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.034 · Cited by 355
The human liver after radiation injury. A form of veno-occlusive disease.
Reed, G., & Cox, A. J. (1966) · PubMed · Cited by 329
Ho, S., Lau, W. Y., Leung, T. W. T., Chan, M., Ngar, Y. K., Johnson, P. J., & Li, A. K. C. (1996) · European Journal of Nuclear Medicine · doi:10.1007/bf01084369 · Cited by 313
Sharma, R. A., Hazel, G. A. V., Morgan, B., Berry, D. P., Blanshard, K., Price, D., Bower, G., Shannon, J. A., Gibbs, P., & Steward, W. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.7916 · Cited by 313
Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
Dancey, J. E., Shepherd, F. A., Paul, K., et al. (2000) · PubMed · Cited by 295
Carr, B. I. (2004) · Liver Transplantation · doi:10.1002/lt.20036 · Cited by 261
Lewandowski, R. J., Thurston, K. G., Goin, J. E., Wong, C.-Y. O., Gates, V. L., Buskirk, M. V., Geschwind, J.-F. H., & Salem, R. (2005) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000179815.44868.66 · Cited by 162
Stubbs, R. S., Cannan, R. J., & Mitchell, A. W. (2001) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(01)80051-2 · Cited by 129
Hepatic venous outflow obstruction: Three similar syndromes
Bayraktar, U. D. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i13.1912 · Cited by 125
Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy
Campbell, A. M., Bailey, I. H., & Burton, M. A. (2001) · Physics in Medicine and Biology · doi:10.1088/0031-9155/46/2/315 · Cited by 122
HEPATIC INJURY FOLLOWING IRRADIATION--A MORPHOLOGIC STUDY--.
OGATA, K., HIZAWA, K., Yoshida, M., et al. (1963) · PubMed · Cited by 77
Lim, L., Gibbs, P., Yip, D., Shapiro, J. D., Dowling, R., Smith, D., Little, A. F., Bailey, W. T., & Liechtenstein, M. (2005) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2005.00789.x · Cited by 71
Zenz, T., Rossle, M. P., Bertz, H., Siegerstetter, V. M., Ochs, A. G., & Finke, J. (2001) · Liver International · doi:10.1034/j.1600-0676.2001.210105.x · Cited by 57
Wickremesekera, J. K., Chen, W., Cannan, R. J., & Stubbs, R. S. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01420-6 · Cited by 37
Cited by
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Bruix, J., Reig, M., & Sherman, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.041 · Cited by 1,694
Sangro, B., Carpanese, L., Cianni, R., Golfieri, R., Gasparini, D., Ezziddin, S., Paprottka, P. M., Fiore, F., Van Buskirk, M., Bilbao, J. I., et al. (2011) · Hepatology · doi:10.1002/hep.24451 · Cited by 652
Self-citationGarin, E., Tselikas, L., Guiu, B., Chalaye, J., Edeline, J., de Baere, T., Assenat, E., Tacher, V., Robert, C., Terroir-Cassou-Mounat, M., et al. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30290-9 · Cited by 630
Gastroenteropancreatic Neuroendocrine Tumors
Cives, M., & Strosberg, J. R. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21493 · Cited by 586
Tsilimigras, D. I., Brodt, P., Clavien, P.-A., Muschel, R. J., D’Angelica, M. I., Endo, I., Parks, R. W., Doyle, M., de Santibañes, E., & Pawlik, T. M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00261-6 · Cited by 556
Metadata
- Authors
- Sangro, B., Gil‐Alzugaray, B., Rodriguez, J., Sola, I., Martinez‐Cuesta, A., Viudez, A., Chopitea, A., Iñarrairaegui, M., Arbizu, J., & Bilbao, J. I.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-03-19
- Volume
- 112
- Issue
- 7
- Pages
- 1538-1546
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2051842222
- Cited by
- 369
- References
- 20
- FWCI
- 7.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.